Respiratory White Papers & Case Studies

  1. SynteractHCR Full-Service CRO Brochure
    3/4/2016

    SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

  2. Treating Cystic Fibrosis: An Evaluation Of An Aerosolized Form Of Levofloxacin
    3/4/2016

    SynteractHCR is a privately held contract research organization (CRO) dedicated to meeting the needs of biotech, pharmaceutical and medical device companies.

  3. MedicINova Changes CROs During Phase II Asthma Trial
    3/4/2016

    SynteractHCR, Inc. was sought out by sponsor MediciNova, a publicly traded biopharmaceutical company headquartered in San Diego, for assistance on a Phase 2 asthma trial, MN-221 Cl-007: A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of MN-221 in adults with acute exacerbations of asthma.

  4. Chronic Obstructive Pulmonary Disease (COPD) Research
    10/20/2015

    As of 2015, InVentiv Health has completed over 70 Phase I-IV respiratory studies of various types – including those involving allergy, asthma, COPD, and cystic fibrosis. That experience has given them significant insight in overcoming the typical logistical and clinical challenges sponsors are normally faced with when conducting respiratory studies.